Choose an Affordable Anti-Herpes Product; polyDNA Recommends Gene-Eden-VIR
| PR Web |
polyDNA recommends Gene-Eden-VIR as the most affordable means of treating a latent herpes infection. As the winter holidays pass, and people break the bank on presents, polyDNA is doing its part to make it easy for individuals to afford a natural remedy against the latent herpes virus.
This week, the media, government agencies, not-for-profits, schools, financial institutions and businesses of all kinds are putting up “After Christmas Sales” or are reminding people why their products or services are better than someone else’s. To help customers who suffer from herpes infections, polyDNA compared the cost of Valtrex, Acyclovir (Zovirax), and Gene-Eden-VIR. The first two are
“I spent so much money on my kids this Christmas! Somehow, the threat of a herpes outbreak kind of got pushed to the back of my mind. I know for sure I won’t have the money to afford Valtrex over the next few months, and that’s especially true since I lost my insurance too. Things just seem to get harder and harder!” – Tamicka R.
According to goodrx.com, the cost of a month’s supply of Valtrex (90 pills), one of the most common anti-herpes medications, is
While Zovirax (Acyclovir) is significantly cheaper, this herpes medication still costs at least
Gene-Eden-VIR is the only natural antiviral product that was tested according to
“We recommend that individuals make New Year’s resolutions that improve their bank account. Choosing Gene-Eden-VIR, an affordable, clinically proven herpes remedy, is a great way to live up to that sort of resolution.” –
In a post marketing clinical study published on
Each ingredient of Gene-Eden-VIR was chosen through a scientific approach. Scientists scanned thousands of scientific and medical papers published in various medical and scientific journals around the world to identify the safest, most effective natural ingredients that target the latent form of herpes. (3)
To learn more about Gene-Eden-VIR, visit http://www.gene-eden-kill-virus.com. All orders of Gene-Eden-VIR are completely confidential, and no information is shared or sold to any third party. Privacy is assured.
Reference:
(1) Goodrx.com - Prices for 90 tablets of Valtrex 1g (brand).
http://www.goodrx.com/valacyclovir#/?filter-location=&coords=&label=Valtrex&form=tablet&strength=1g&quantity=custom&qty-custom=90
(2) Goodrx.com - Prices for 200 ml of 200mg/5ml Zovirax oral suspension (brand).
http://www.goodrx.com/acyclovir#/?filter-location=&coords=&label=Zovirax&form=oral+suspension&strength=200mg&quantity=custom&qty-custom=30
(3) Gene-Eden-VIR Is Antiviral: Results of a Post Marketing
Clinical Study. Published on
http://gene-eden-kill-virus.com/PP_Gene-Eden-VIR-is-Antiviral.pdf
polyDNA is a biotechnology company that develops dietary supplements using the unique scientific method developed by Dr.
In addition to his unique scientific method, Dr. Polansky published the highly acclaimed scientific discovery, called Microcompetition with Foreign DNA. The discovery explains how foreign DNA fragments, and specifically, DNA of latent viruses, cause most major diseases.
polyDNA developed Gene-Eden-VIR , an antiviral natural remedy that helps the immune system kill latent viruses.
Read the full story at http://www.prweb.com/releases/2013/12/prweb11449868.htm
| Copyright: | (c) 2013 PRWEB.COM Newswire |
| Wordcount: | 598 |



Advisor News
- Metlife study finds less than half of US workforce holistically healthy
- Invigorating client relationships with AI coaching
- SEC: Get-rich-quick influencer Tai Lopez was running a Ponzi scam
- Companies take greater interest in employee financial wellness
- Tax refund won’t do what fed says it will
More Advisor NewsAnnuity News
- The structural rise of structured products
- How next-gen pricing tech can help insurers offer better annuity products
- Continental General Acquires Block of Life Insurance, Annuity and Health Policies from State Guaranty Associations
- Lincoln reports strong life/annuity sales, executes with ‘discipline and focus’
- LIMRA launches the Lifetime Income Initiative
More Annuity NewsHealth/Employee Benefits News
- Bloomfield-based health care giant Cigna plans to lay off 2,000 employees worldwide
- Striking nurses back bill requiring health plans that receive state subsidies to disclose investments
- More than 50,000 in Mass. lose insurance plans after Congress fails to extend subsidies
- Bloomfield-based health care giant Cigna plans to lay off 2,000 employees worldwide
- STATEHOUSE: 'We don't see the savings': Indiana Medicaid restructuring bill draws pushback
More Health/Employee Benefits NewsLife Insurance News